Head-to-Head lupus drug study aims to find better treatment
NCT ID NCT07069972
Summary
This study will compare two existing medications for systemic lupus erythematosus (SLE) to see which works better and is safer. Researchers will observe 180 adults with moderate-to-severe lupus who choose either telitacicept or belimumab alongside their current treatments. The study will track how well each drug controls lupus symptoms and improves kidney function in patients with lupus nephritis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.